Twenty-four quinoxaline derivatives were evaluated for their antimycobacterial activity using BacTiter-Glo microbial cell viability assay. Five compounds showed MIC values <3.1 μM and IC50 values <1.5 μM in primary screening and therefore, they were moved on for further evaluation. Compounds 21 and 18 stand out, showing MIC values of 1.6 μM and IC50 values of 0.5 and 1.0 μM, respectively. Both compounds
使用BacTiter-Glo微
生物细胞生存力测定法评估了24种
喹喔啉衍
生物的抗分枝杆菌活性。五个化合物在初次筛选时的MIC值<3.1μM,IC 50值<1.5μM,因此,他们继续进行进一步的评估。化合物21和18脱颖而出,分别显示MIC值为1.6μM和IC 50值为0.5和1.0μM。两种化合物对三种评估的耐药菌株均最有效。此外,考虑到对数减少和细胞活力,它们在感染的巨噬细胞中表现出细胞内活性。此外,化合物16和21对非复制有效结核分枝杆菌和化合物21具有杀菌作用。因此,可以考虑使用喹喔啉衍
生物在抗分枝杆菌药的未来发展中取得进一步的进展。